Advancing Botanical Drug Development Act of 2026
Referred to the House Committee on Energy and Commerce.
Email me when HR 10150 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 10150. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill changes federal drug law so that products derived from plants can enjoy a set time of exclusive market rights. This would affect companies that develop botanical medicines and could encourage more research into plant‑based treatments. It is currently referred to the House Energy and Commerce Committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 10150
3 free questions a day, no accountSponsors
- Rep. Boebert, Lauren [R-CO-4] (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 10150 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 10150 freeOr ask your AI assistant about HR 10150 directly:
Add to Claude, ChatGPT or Cursor